{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:22:40Z","timestamp":1792650160375,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00284-022-02949-8","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T07:06:52Z","timestamp":1658214412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Evaluating the Performance of PPE44, HSPX, ESAT-6 and CFP-10 Factors in Tuberculosis Subunit Vaccines"],"prefix":"10.1007","volume":"79","author":[{"given":"Azar","family":"Valizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas Ali","family":"imani Fooladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Sedighian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Mahboobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Gholami Parizad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Behzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afra","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"issue":"4","key":"2949_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/icb.2009.14","volume":"87","author":"C Aagaard","year":"2009","unstructured":"Aagaard C, Dietrich J, Doherty M, Andersen P (2009) TB vaccines: current status and future perspectives. Immunol Cell Biol 87(4):279\u2013286","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"2949_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.coi.2010.04.006","volume":"22","author":"SK Parida","year":"2010","unstructured":"Parida SK, Kaufmann SH (2010) Novel tuberculosis vaccines on the horizon. Curr Opin Immunol 22(3):374\u2013384","journal-title":"Curr Opin Immunol"},{"key":"2949_CR3","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.ijid.2021.02.107","volume":"113","author":"J Chakaya","year":"2021","unstructured":"Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P et al (2021) Global tuberculosis report 2020\u2013reflections on the global TB burden, treatment and prevention efforts. Int J Infect Dis 113:S7\u2013S12","journal-title":"Int J Infect Dis"},{"issue":"1","key":"2949_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jiph.2014.08.005","volume":"8","author":"B Farzam","year":"2015","unstructured":"Farzam B, Fooladi AAI, Izadi M, Hossaini HM, Feizabadi MM (2015) Comparison of cyp141 and IS6110 for detection of Mycobacterium tuberculosis from clinical specimens by PCR. J Infect Public Health 8(1):32\u201336","journal-title":"J Infect Public Health"},{"issue":"2","key":"2949_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1046\/j.1365-2958.2003.03844.x","volume":"51","author":"KM Guinn","year":"2004","unstructured":"Guinn KM, Hickey MJ, Mathur SK, Zakel KL, Grotzke JE, Lewinsohn DM et al (2004) Individual RD1-region genes are required for export of ESAT-6\/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbiol 51(2):359\u2013370","journal-title":"Mol Microbiol"},{"issue":"3","key":"2949_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.imbio.2011.07.008","volume":"217","author":"A Gupta","year":"2012","unstructured":"Gupta A, Kaul A, Tsolaki AG, Kishore U, Bhakta S (2012) Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology 217(3):363\u2013374","journal-title":"Immunobiology"},{"key":"2949_CR7","first-page":"293","volume":"47","author":"C Beard","year":"2003","unstructured":"Beard C (2003) The role of vaccines and vaccination. Avian Dis 47:293\u2013305","journal-title":"Avian Dis"},{"issue":"3","key":"2949_CR8","first-page":"585","volume":"17","author":"JA Roth","year":"2001","unstructured":"Roth JA, Henderson LM (2001) New technology for improved vaccine safety and efficacy. Vet Clin North Am 17(3):585\u2013597","journal-title":"Vet Clin North Am"},{"key":"2949_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-018-0057-5","author":"RN Coler","year":"2018","unstructured":"Coler RN, Day TA, Ellis R, Piazza FM, Beckmann AM, Vergara J et al (2018) The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial. NPJ Vaccines. https:\/\/doi.org\/10.1038\/s41541-018-0057-5","journal-title":"NPJ Vaccines"},{"key":"2949_CR10","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","volume":"8","author":"NE Nieuwenhuizen","year":"2017","unstructured":"Nieuwenhuizen NE, Kulkarni PS, Shaligram U, Cotton MF, Rentsch CA, Eisele B et al (2017) The recombinant bacille calmette-gu\u00e9rin vaccine VPM1002: ready for clinical efficacy testing. Front Immunol 8:1147","journal-title":"Front Immunol"},{"issue":"2","key":"2949_CR11","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s10989-020-10147-y","volume":"27","author":"M Mahboobi","year":"2020","unstructured":"Mahboobi M, Sedighian H, Malekara E, Khalili S, Rahbar MR, Zanoos KA et al (2020) Harnessing an integrative in silico approach to engage highly immunogenic peptides in an antigen design against epsilon toxin (ETX) of clostridium perfringens. Int J Pept Res Ther 27(2):1019\u20131026","journal-title":"Int J Pept Res Ther"},{"key":"2949_CR12","first-page":"10","volume":"3","author":"M Mahboobi","year":"2017","unstructured":"Mahboobi M, Sedighian H, Hedayati CHM, Bambai B, Esmaeil Soofian S, Amani J (2017) Applying bioinformatic tools for modeling and modifying type ii e. Coli l-asparginase to present a better therapeutic agent\/drug for acute lymphoblastic leukemia. Int J Cancer Manag 3:10","journal-title":"Int J Cancer Manag"},{"issue":"4","key":"2949_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.30699\/IJP.2019.101200.2004","volume":"14","author":"ZM Moghadam","year":"2019","unstructured":"Moghadam ZM, Halabian R, Sedighian H, Behzadi E, Amani J, Fooladi AAI (2019) Designing and analyzing the structure of DT-STXB fusion protein as an anti-tumor agent: an in silico approach. Iran J Pathol 14(4):305","journal-title":"Iran J Pathol"},{"key":"2949_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.molimm.2018.03.007","volume":"97","author":"P Shah","year":"2018","unstructured":"Shah P, Mistry J, Reche PA, Gatherer D, Flower DR (2018) In silico design of Mycobacterium tuberculosis epitope ensemble vaccines. Mol Immunol 97:56\u201362","journal-title":"Mol Immunol"},{"issue":"1","key":"2949_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-40621-7","volume":"9","author":"M Shahbaaz","year":"2019","unstructured":"Shahbaaz M, Nkaule A, Christoffels A (2019) Designing novel possible kinase inhibitor derivatives as therapeutics against Mycobacterium tuberculosis: an in silico study. Sci Rep 9(1):1\u201312","journal-title":"Sci Rep"},{"issue":"4","key":"2949_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.artd.2019.08.004","volume":"5","author":"A Williams","year":"2019","unstructured":"Williams A, Arnold B, Gwynne-Jones DP (2019) Mycobacterium bovis infection of total hip arthroplasty after intravesicular bacillus calmette-gu\u00e9rin. Arthroplast Today 5(4):416\u2013420","journal-title":"Arthroplast Today"},{"key":"2949_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00100-19","author":"SB Sable","year":"2019","unstructured":"Sable SB, Posey JE, Scriba TJ (2019) Tuberculosis vaccine development: progress in clinical evaluation. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/CMR.00100-19","journal-title":"Clin Microbiol Rev"},{"key":"2949_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ebiom.2016.04.010","volume":"7","author":"DF Hoft","year":"2016","unstructured":"Hoft DF, Blazevic A, Selimovic A, Turan A, Tennant J, Abate G et al (2016) Safety and immunogenicity of the recombinant BCG vaccine AERAS-422 in healthy BCG-na\u00efve adults: a randomized, active-controlled, first-in-human phase 1 trial. EBioMedicine 7:278\u2013286","journal-title":"EBioMedicine"},{"issue":"12","key":"2949_CR19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S2213-2600(15)00435-X","volume":"3","author":"F Spertini","year":"2015","unstructured":"Spertini F, Audran R, Chakour R, Karoui O, Steiner-Monard V, Thierry A-C et al (2015) Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial. Lancet Respir Med 3(12):953\u2013962","journal-title":"Lancet Respir Med"},{"issue":"2","key":"2949_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa1714021","volume":"379","author":"E Nemes","year":"2018","unstructured":"Nemes E, Geldenhuys H, Rozot V, Rutkowski KT, Ratangee F, Bilek N et al (2018) Prevention of M. tuberculosis infection with H4: IC31 vaccine or BCG revaccination. N Engl J Med 379(2):138\u201349","journal-title":"N Engl J Med"},{"issue":"17","key":"2949_CR21","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","volume":"379","author":"O Van Der Meeren","year":"2018","unstructured":"Van Der Meeren O, Hatherill M, Nduba V, Wilkinson RJ, Muyoyeta M, Van Brakel E et al (2018) Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis. N Engl J Med 379(17):1621\u20131634","journal-title":"N Engl J Med"},{"issue":"9871","key":"2949_CR22","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","volume":"381","author":"MD Tameris","year":"2013","unstructured":"Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S et al (2013) Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. The Lancet 381(9871):1021\u20131028","journal-title":"The Lancet"},{"issue":"9","key":"2949_CR23","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1128\/IAI.02145-14","volume":"82","author":"MS Duthie","year":"2014","unstructured":"Duthie MS, Coler RN, Laurance JD, Sampaio LH, Oliveira RM, Sousa ALM et al (2014) Protection against Mycobacterium leprae infection by the ID83\/GLA-SE and ID93\/GLA-SE vaccines developed for tuberculosis. Infect Immun 82(9):3979\u20133985","journal-title":"Infect Immun"},{"issue":"4","key":"2949_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002791","volume":"16","author":"J Vekemans","year":"2019","unstructured":"Vekemans J, O\u2019Brien KL, Farrar J (2019) Tuberculosis vaccines: rising opportunities. PLoS Med 16(4):e1002791","journal-title":"PLoS Med"},{"issue":"12","key":"2949_CR25","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","volume":"181","author":"B Abel","year":"2010","unstructured":"Abel B, Tameris M, Mansoor N, Gelderbloem S, Hughes J, Abrahams D et al (2010) The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am J Respir Crit Care Med 181(12):1407\u20131417","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2949_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/intimm\/9.5.713","volume":"9","author":"ME Munk","year":"1997","unstructured":"Munk ME, Kern P, Kaufmann S (1997) Human CD30+ cells are induced by Mycobacterium tuberculosis and present in tuberculosis lesions. Int Immunol 9(5):713\u2013720","journal-title":"Int Immunol"},{"key":"2949_CR27","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3389\/fimmu.2018.02127","volume":"9","author":"R Arrigucci","year":"2018","unstructured":"Arrigucci R, Lakehal K, Vir P, Handler D, Davidow A, Herrera R et al (2018) Active tuberculosis is characterized by highly differentiated effector memory Th1 cells. Front Immunol 9:2127","journal-title":"Front Immunol"},{"key":"2949_CR28","doi-asserted-by":"publisher","DOI":"10.5812\/modernc.91493","author":"M Keikha","year":"2019","unstructured":"Keikha M, Karbalaei M (2019) Can multi-stage recombinant fusion proteins be considered as reliable vaccines against tuberculosis? a letter to the editor. Mod Care J. https:\/\/doi.org\/10.5812\/modernc.91493","journal-title":"Mod Care J"},{"issue":"5","key":"2949_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.tube.2011.04.004","volume":"91","author":"S Mukhopadhyay","year":"2011","unstructured":"Mukhopadhyay S, Balaji KN (2011) The PE and PPE proteins of Mycobacterium tuberculosis. Tuberculosis 91(5):441\u2013447","journal-title":"Tuberculosis"},{"issue":"6482","key":"2949_CR30","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1126\/science.aav5912","volume":"367","author":"Q Wang","year":"2020","unstructured":"Wang Q, Boshoff HI, Harrison JR, Ray PC, Green SR, Wyatt PG et al (2020) PE\/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis. Science 367(6482):1147\u20131151","journal-title":"Science"},{"issue":"5","key":"2949_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1099\/jmm.0.45960-0","volume":"54","author":"D Bonanni","year":"2005","unstructured":"Bonanni D, Rindi L, Lari N, Garzelli C (2005) Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice. J Med Microbiol 54(5):443\u2013448","journal-title":"J Med Microbiol"},{"issue":"4","key":"2949_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11515-018-1494-2","volume":"13","author":"A Yousefi-Avarvand","year":"2018","unstructured":"Yousefi-Avarvand A, Tafaghodi M, Soleimanpour S, Khademi F (2018) HspX protein as a candidate vaccine against Mycobacterium tuberculosis: an overview. Front Biol 13(4):293\u2013296","journal-title":"Front Biol"},{"issue":"10","key":"2949_CR33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/icb.2012.34","volume":"90","author":"JL Taylor","year":"2012","unstructured":"Taylor JL, Wieczorek A, Keyser AR, Grover A, Flinkstrom R, Karls RK et al (2012) HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule. Immunol Cell Biol 90(10):945\u2013954","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"2949_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122560","volume":"10","author":"X Wang","year":"2015","unstructured":"Wang X, Zhang J, Liang J, Zhang Y, Teng X, Yuan X et al (2015) Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-\u03b3+ IL-2+ CD4+ and IFN-\u03b3+ CD8+ T cells. PLoS ONE 10(3):e0122560","journal-title":"PLoS ONE"},{"issue":"1","key":"2949_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-7-148","volume":"7","author":"MF Rabahi","year":"2007","unstructured":"Rabahi MF, Junqueira-Kipnis AP, Dos Reis MCG, Oelemann W, Conde MB (2007) Humoral response to HspX and GlcB to previous and recent infection by Mycobacterium tuberculosis. BMC Infect Dis 7(1):1\u20139","journal-title":"BMC Infect Dis"},{"issue":"10","key":"2949_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075684","volume":"8","author":"L Marongiu","year":"2013","unstructured":"Marongiu L, Donini M, Toffali L, Zenaro E, Dusi S (2013) ESAT-6 and HspX improve the effectiveness of BCG to induce human dendritic cells-dependent Th1 and NK cells activation. PLoS ONE 8(10):e75684","journal-title":"PLoS ONE"},{"key":"2949_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fcimb.2018.00327","volume":"8","author":"A Refai","year":"2018","unstructured":"Refai A, Gritli S, Barbouche M-R, Essafi M (2018) Mycobacterium tuberculosis virulent factor ESAT-6 drives macrophage differentiation toward the pro-inflammatory M1 phenotype and subsequently switches it to the anti-inflammatory M2 phenotype. Front Cell Infect Microbiol 8:327","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2949_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/iai.64.1.16-22.1996","volume":"64","author":"M Harboe","year":"1996","unstructured":"Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P (1996) Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 64(1):16\u201322","journal-title":"Infect Immun"},{"key":"2949_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.biologicals.2019.04.002","volume":"59","author":"M Namvarpour","year":"2019","unstructured":"Namvarpour M, Tebianian M, Mansouri R, Ebrahimi SM, Kashkooli S (2019) Comparison of different immunization routes on the immune responses induced by Mycobacterium tuberculosis ESAT-6\/CFP-10 recombinant protein. Biologicals 59:6\u201311","journal-title":"Biologicals"},{"issue":"9","key":"2949_CR40","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1128\/JCM.38.9.3285-3290.2000","volume":"38","author":"DC Dillon","year":"2000","unstructured":"Dillon DC, Alderson MR, Day CH, Bement T, Campos-Neto A, Skeiky YA et al (2000) Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. J Clin Microbiol 38(9):3285\u20133290","journal-title":"J Clin Microbiol"},{"issue":"8","key":"2949_CR41","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.4161\/hv.29574","volume":"10","author":"DO Villarreal","year":"2014","unstructured":"Villarreal DO, Walters J, Laddy DJ, Yan J, Weiner DB (2014) Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG. Hum Vaccin Immunother 10(8):2188\u20132198","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"2949_CR42","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2958.2009.06784.x","volume":"73","author":"D Bottai","year":"2009","unstructured":"Bottai D, Brosch R (2009) Mycobacterial PE, PPE and ESX clusters: novel insights into the secretion of these most unusual protein families. Mol Microbiol 73(3):325\u2013328","journal-title":"Mol Microbiol"},{"issue":"17","key":"2949_CR43","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.vaccine.2012.05.035","volume":"31","author":"I Leroux-Roels","year":"2013","unstructured":"Leroux-Roels I, Forgus S, De Boever F, Clement F, Demoiti\u00e9 M-A, Mettens P et al (2013) Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial. Vaccine 31(17):2196\u20132206","journal-title":"Vaccine"},{"issue":"3","key":"2949_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S2213-2600(15)00037-5","volume":"3","author":"BP Ndiaye","year":"2015","unstructured":"Ndiaye BP, Thienemann F, Ota M, Landry BS, Camara M, Di\u00e8ye S et al (2015) Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial. Lancet Respir Med 3(3):190\u2013200","journal-title":"Lancet Respir Med"},{"key":"2949_CR45","doi-asserted-by":"crossref","unstructured":"Russo G, Pappalardo F, Juarez MA, Pennisi M, Cardona PJ, Coler R et al (2019) Evaluation of the efficacy of RUTI and ID93\/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator. arXiv preprint arXiv:191100325","DOI":"10.1109\/BIBM47256.2019.8983060"},{"issue":"4","key":"2949_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018773","volume":"6","author":"B Dey","year":"2011","unstructured":"Dey B, Jain R, Khera A, Gupta UD, Katoch V, Ramanathan V et al (2011) Latency antigen \u03b1-crystallin based vaccination imparts a robust protection against TB by modulating the dynamics of pulmonary cytokines. PLoS ONE 6(4):e18773","journal-title":"PLoS ONE"},{"issue":"7","key":"2949_CR47","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1086\/423938","volume":"190","author":"P Chakhaiyar","year":"2004","unstructured":"Chakhaiyar P, Nagalakshmi Y, Aruna B, Murthy KJ, Katoch VM, Hasnain SE (2004) Regions of high antigenicity within the hypothetical PPE major polymorphic tandem repeat open-reading frame, Rv2608, show a differential humoral response and a low T cell response in various categories of patients with tuberculosis. J Infect Dis 190(7):1237\u20131244","journal-title":"J Infect Dis"},{"issue":"6","key":"2949_CR48","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.1002\/jcp.27608","volume":"234","author":"W Li","year":"2019","unstructured":"Li W, Deng W, Xie J (2019) Expression and regulatory networks of Mycobacterium tuberculosis PE\/PPE family antigens. J Cell Physiol 234(6):7742\u20137751","journal-title":"J Cell Physiol"},{"issue":"3","key":"2949_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007643","volume":"15","author":"MJ Rodo","year":"2019","unstructured":"Rodo MJ, Rozot V, Nemes E, Dintwe O, Hatherill M, Little F et al (2019) A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates. PLoS Pathog 15(3):e1007643","journal-title":"PLoS Pathog"},{"issue":"1","key":"2949_CR50","doi-asserted-by":"publisher","first-page":"e01712","DOI":"10.1128\/mBio.01712-17","volume":"9","author":"J Ahmad","year":"2018","unstructured":"Ahmad J, Farhana A, Pancsa R, Arora SK, Srinivasan A, Tyagi AK et al (2018) Contrasting function of structured N-terminal and unstructured C-terminal segments of Mycobacterium tuberculosis PPE37 protein. MBio 9(1):e01712-e1717","journal-title":"MBio"},{"issue":"3","key":"2949_CR51","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1365-2958.1999.01383.x","volume":"32","author":"SV Gordon","year":"1999","unstructured":"Gordon SV, Brosch R, Billault A, Garnier T, Eiglmeier K, Cole ST (1999) Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 32(3):643\u2013655","journal-title":"Mol Microbiol"},{"issue":"1","key":"2949_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2148-6-95","volume":"6","author":"NCG Van Pittius","year":"2006","unstructured":"Van Pittius NCG, Sampson SL, Lee H, Kim Y, Van Helden PD, Warren RM (2006) Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol Biol 6(1):95","journal-title":"BMC Evol Biol"},{"issue":"11","key":"2949_CR53","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1080\/17460441.2020.1791076","volume":"15","author":"G Russo","year":"2020","unstructured":"Russo G, Reche P, Pennisi M, Pappalardo F (2020) The combination of artificial intelligence and systems biology for intelligent vaccine design. Expert Opin Drug Discov 15(11):1267\u20131281","journal-title":"Expert Opin Drug Discov"},{"issue":"16","key":"2949_CR54","doi-asserted-by":"publisher","first-page":"6028","DOI":"10.1128\/JB.00469-07","volume":"189","author":"MI De Jonge","year":"2007","unstructured":"De Jonge MI, Pehau-Arnaudet G, Fretz MM, Romain F, Bottai D, Brodin P et al (2007) ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J Bacteriol 189(16):6028\u20136034","journal-title":"J Bacteriol"},{"issue":"2","key":"2949_CR55","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1040638718824074","volume":"31","author":"S Scherrer","year":"2019","unstructured":"Scherrer S, Landolt P, Friedel U, Stephan R (2019) Distribution and expression of esat-6 and cfp-10 in non-tuberculous mycobacteria isolated from lymph nodes of slaughtered cattle in Switzerland. J Vet Diagn Invest 31(2):217\u2013221","journal-title":"J Vet Diagn Invest"},{"issue":"3\u20134","key":"2949_CR56","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tube.2006.01.005","volume":"86","author":"R Pajon","year":"2006","unstructured":"Pajon R, Yero D, Lage A, Llanes A, Borroto C (2006) Computational identification of beta-barrel outer-membrane proteins in Mycobacterium tuberculosis predicted proteomes as putative vaccine candidates. Tuberculosis 86(3\u20134):290\u2013302","journal-title":"Tuberculosis"},{"key":"2949_CR57","first-page":"664","volume":"5","author":"NK Singh","year":"1814","unstructured":"Singh NK, Goodman A, Walter P, Helms V, Hayat S (1814) 2011 TMBHMM: a frequency profile based HMM for predicting the topology of transmembrane beta barrel proteins and the exposure status of transmembrane residues. Biochim et Biophys Acta 5:664\u201370","journal-title":"Biochim et Biophys Acta"},{"issue":"3","key":"2949_CR58","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.coi.2009.05.017","volume":"21","author":"LF Barker","year":"2009","unstructured":"Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC (2009) Tuberculosis vaccine research: the impact of immunology. Curr Opin Immunol 21(3):331\u2013338","journal-title":"Curr Opin Immunol"},{"key":"2949_CR59","doi-asserted-by":"publisher","first-page":"16085","DOI":"10.1038\/ncomms16085","volume":"8","author":"N Aguilo","year":"2017","unstructured":"Aguilo N, Gonzalo-Asensio J, Alvarez-Arguedas S, Marinova D, Gomez AB, Uranga S et al (2017) Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis. Nat Commun 8:16085","journal-title":"Nat Commun"},{"issue":"8","key":"2949_CR60","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1128\/JB.186.8.2487-2491.2004","volume":"186","author":"LM Okkels","year":"2004","unstructured":"Okkels LM, Andersen P (2004) Protein-protein interactions of proteins from the ESAT-6 family of Mycobacterium tuberculosis. J Bacteriol 186(8):2487\u20132491","journal-title":"J Bacteriol"},{"issue":"12","key":"2949_CR61","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1073\/pnas.1231432100","volume":"100","author":"G Lamichhane","year":"2003","unstructured":"Lamichhane G, Zignol M, Blades NJ, Geiman DE, Dougherty A, Grosset J et al (2003) A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 100(12):7213\u20137218","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2949_CR62","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.4049\/jimmunol.165.12.7140","volume":"165","author":"YA Skeiky","year":"2000","unstructured":"Skeiky YA, Ovendale PJ, Jen S, Alderson MR, Dillon DC, Smith S et al (2000) T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection. J Immunol 165(12):7140\u20137149","journal-title":"J Immunol"},{"issue":"10","key":"2949_CR63","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1128\/IAI.01495-08","volume":"77","author":"RM Goldstone","year":"2009","unstructured":"Goldstone RM, Goonesekera SD, Bloom BR, Sampson SL (2009) The transcriptional regulator Rv0485 modulates the expression of a pe and ppe gene pair and is required for Mycobacterium tuberculosis virulence. Infect Immun 77(10):4654\u20134667","journal-title":"Infect Immun"},{"key":"2949_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fcimb.2016.00049","volume":"6","author":"S Shah","year":"2016","unstructured":"Shah S, Briken V (2016) Modular organization of the ESX-5 secretion system in Mycobacterium tuberculosis. Front Cell Infect Microbiol 6:49","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"2949_CR65","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.micinf.2006.11.013","volume":"9","author":"KN Balaji","year":"2007","unstructured":"Balaji KN, Goyal G, Narayana Y, Srinivas M, Chaturvedi R, Mohammad S (2007) Apoptosis triggered by Rv1818c, a PE family gene from Mycobacterium tuberculosis is regulated by mitochondrial intermediates in T cells. Microbes Infect 9(3):271\u2013281","journal-title":"Microbes Infect"},{"issue":"5","key":"2949_CR66","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.febslet.2006.01.042","volume":"580","author":"S Tundup","year":"2006","unstructured":"Tundup S, Akhter Y, Thiagarajan D, Hasnain SE (2006) Clusters of PE and PPE genes of Mycobacterium tuberculosis are organized in operons: evidence that PE Rv2431c is co-transcribed with PPE Rv2430c and their gene products interact with each other. FEBS Lett 580(5):1285\u20131293","journal-title":"FEBS Lett"},{"issue":"4","key":"2949_CR67","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1128\/IAI.71.4.1763-1773.2003","volume":"71","author":"S Worku","year":"2003","unstructured":"Worku S, Hoft D (2003) Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Infect Immun 71(4):1763\u20131773","journal-title":"Infect Immun"},{"issue":"5470","key":"2949_CR68","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.288.5470.1436","volume":"288","author":"L Ramakrishnan","year":"2000","unstructured":"Ramakrishnan L, Federspiel NA, Falkow S (2000) Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288(5470):1436\u20131439","journal-title":"Science"},{"issue":"2","key":"2949_CR69","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1074\/jbc.M604379200","volume":"282","author":"S Basu","year":"2007","unstructured":"Basu S, Pathak SK, Banerjee A, Pathak S, Bhattacharyya A, Yang Z et al (2007) Execution of macrophage apoptosis by PE_PGRS33 of Mycobacterium tuberculosis is mediated by Toll-like receptor 2-dependent release of tumor necrosis factor-\u03b1. J Biol Chem 282(2):1039\u20131050","journal-title":"J Biol Chem"},{"issue":"9","key":"2949_CR70","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1084\/jem.20031072","volume":"198","author":"LM Stamm","year":"2003","unstructured":"Stamm LM, Morisaki JH, Gao L-Y, Jeng RL, McDonald KL, Roth R et al (2003) Mycobacterium marinum escapes from phagosomes and is propelled by actin-based motility. J Exp Med 198(9):1361\u20131368","journal-title":"J Exp Med"},{"issue":"5","key":"2949_CR71","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00281-013-0388-2","volume":"35","author":"E Guirado","year":"2013","unstructured":"Guirado E, Schlesinger LS, Kaplan G (2013) Macrophages in tuberculosis: friend or foe. Semin Immunopathol 35(5):563\u2013583","journal-title":"Semin Immunopathol"},{"issue":"7","key":"2949_CR72","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.4049\/jimmunol.0903299","volume":"184","author":"K Bansal","year":"2010","unstructured":"Bansal K, Elluru SR, Narayana Y, Chaturvedi R, Patil SA, Kaveri SV et al (2010) PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells. J Immunol 184(7):3495\u20133504","journal-title":"J Immunol"},{"issue":"10","key":"2949_CR73","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.4049\/jimmunol.0901367","volume":"183","author":"S Nair","year":"2009","unstructured":"Nair S, Ramaswamy PA, Ghosh S, Joshi DC, Pathak N, Siddiqui I et al (2009) The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage. J Immunol 183(10):6269\u20136281","journal-title":"J Immunol"},{"issue":"6","key":"2949_CR74","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1073\/pnas.052548299","volume":"99","author":"R Brosch","year":"2002","unstructured":"Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K et al (2002) A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 99(6):3684\u20133689","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2949_CR75","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1128\/IAI.67.6.2941-2950.1999","volume":"67","author":"DC Dillon","year":"1999","unstructured":"Dillon DC, Alderson MR, Day CH, Lewinsohn DM, Coler R, Bement T et al (1999) Molecular characterization and human t-cell responses to a member of a novel Mycobacterium tuberculosis mtb39Gene family. Infect Immun 67(6):2941\u20132950","journal-title":"Infect Immun"},{"issue":"5","key":"2949_CR76","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","volume":"178","author":"GG Mahairas","year":"1996","unstructured":"Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK (1996) Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178(5):1274\u201382","journal-title":"J Bacteriol"},{"issue":"6","key":"2949_CR77","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.4049\/jimmunol.174.6.3734","volume":"174","author":"H Takatori","year":"2005","unstructured":"Takatori H, Nakajima H, Hirose K, Kagami S-i, Tamachi T, Suto A et al (2005) Indispensable role of Stat5a in Stat6-independent Th2 cell differentiation and allergic airway inflammation. J Immunol 174(6):3734\u201340","journal-title":"J Immunol"},{"issue":"11","key":"2949_CR78","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1089\/jir.2005.25.694","volume":"25","author":"C Manca","year":"2005","unstructured":"Manca C, Tsenova L, Freeman S, Barczak AK, Tovey M, Murray PJ et al (2005) Hypervirulent M. tuberculosis W\/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J Interferon Cytokine Res 25(11):694\u2013701","journal-title":"J Interferon Cytokine Res"},{"issue":"11","key":"2949_CR79","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.tim.2004.09.007","volume":"12","author":"P Brodin","year":"2004","unstructured":"Brodin P, Rosenkrands I, Andersen P, Cole ST, Brosch R (2004) ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol 12(11):500\u2013508","journal-title":"Trends Microbiol"},{"issue":"4","key":"2949_CR80","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1745-7270.2007.00281.x","volume":"39","author":"C Shi","year":"2007","unstructured":"Shi C, Wang X, Zhang H, Xu Z, Li Y, Yuan L (2007) Immune responses and protective efficacy induced by 85B antigen and early secreted antigenic target-6 kDa antigen fusion protein secreted by recombinant bacille Calmette-Gu\u00e9rin. Acta Biochim Biophys Sin 39(4):290\u2013296","journal-title":"Acta Biochim Biophys Sin"},{"issue":"11","key":"2949_CR81","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1084\/jem.20041690","volume":"200","author":"AB Kamath","year":"2004","unstructured":"Kamath AB, Woodworth J, Xiong X, Taylor C, Weng Y, Behar SM (2004) Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection. J Exp Med 200(11):1479\u20131489","journal-title":"J Exp Med"},{"issue":"2","key":"2949_CR82","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1128\/IAI.01137-06","volume":"75","author":"V Roupie","year":"2007","unstructured":"Roupie V, Romano M, Zhang L, Korf H, Lin MY, Franken KL et al (2007) Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect Immun 75(2):941\u2013949","journal-title":"Infect Immun"},{"issue":"14","key":"2949_CR83","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/j.vaccine.2011.06.029","volume":"30","author":"W Yuan","year":"2012","unstructured":"Yuan W, Dong N, Zhang L, Liu J, Lin S, Xiang Z et al (2012) Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Vaccine 30(14):2490\u20132497","journal-title":"Vaccine"},{"issue":"3","key":"2949_CR84","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.micinf.2010.11.002","volume":"13","author":"B-Y Jeon","year":"2011","unstructured":"Jeon B-Y, Kim S-C, Eum S-Y, Cho S-N (2011) The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis. Microbes Infect 13(3):284\u2013290","journal-title":"Microbes Infect"},{"issue":"1","key":"2949_CR85","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.micinf.2011.08.011","volume":"14","author":"M Romano","year":"2012","unstructured":"Romano M, Aryan E, Korf H, Bruffaerts N, Franken C, Ottenhoff T et al (2012) Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines. Microbes Infect 14(1):86\u201395","journal-title":"Microbes Infect"},{"issue":"5","key":"2949_CR86","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1365-3083.2009.02325.x","volume":"70","author":"C Shi","year":"2009","unstructured":"Shi C, Zhang H, Zhang T, Wang X, Bai B, Zhao Y et al (2009) New alternative vaccine component against Mycobacterium tuberculosis-heat shock protein 16.3 or its T-cell epitope. Scand J Immunol. 70(5):465\u2013474","journal-title":"Scand J Immunol."},{"issue":"32","key":"2949_CR87","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1016\/j.vaccine.2010.05.063","volume":"28","author":"C Shi","year":"2010","unstructured":"Shi C, Chen L, Chen Z, Zhang Y, Zhou Z, Lu J et al (2010) Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein. Vaccine 28(32):5237\u20135244","journal-title":"Vaccine"},{"issue":"10","key":"2949_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047781","volume":"7","author":"EM De Sousa","year":"2012","unstructured":"De Sousa EM, da Costa AC, Trentini MM, de Araujo Filho JA, Kipnis A, Junqueira-Kipnis AP (2012) Immunogenicity of a fusion protein containing immunodominant epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in mice and active TB infection. PLoS ONE 7(10):e47781","journal-title":"PLoS ONE"},{"issue":"51","key":"2949_CR89","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1016\/j.vaccine.2011.10.032","volume":"29","author":"H Niu","year":"2011","unstructured":"Niu H, Hu L, Li Q, Da Z, Wang B, Tang K et al (2011) Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10. 4\u2013HspX. Vaccine 29(51):9451\u20139458","journal-title":"Vaccine"},{"issue":"3","key":"2949_CR90","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/2049-632X.12147","volume":"71","author":"AE Wieczorek","year":"2014","unstructured":"Wieczorek AE, Troudt JL, Knabenbauer P, Taylor J, Pavlicek RL, Karls R et al (2014) HspX vaccination and role in virulence in the guinea pig model of tuberculosis. Pathog Dis 71(3):315\u2013325","journal-title":"Pathog Dis"},{"issue":"4","key":"2949_CR91","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1128\/JB.180.4.801-808.1998","volume":"180","author":"AF Cunningham","year":"1998","unstructured":"Cunningham AF, Spreadbury CL (1998) Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton \u03b1-crystallin homolog. J Bacteriol 180(4):801\u2013808","journal-title":"J Bacteriol"},{"issue":"6707","key":"2949_CR92","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/24206","volume":"396","author":"S Cole","year":"1998","unstructured":"Cole S, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D et al (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 396(6707):190","journal-title":"Nature"},{"issue":"5","key":"2949_CR93","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.tube.2011.01.003","volume":"91","author":"AK Tyagi","year":"2011","unstructured":"Tyagi AK, Nangpal P, Satchidanandam V (2011) Development of vaccines against tuberculosis. Tuberculosis 91(5):469\u2013478","journal-title":"Tuberculosis"},{"issue":"24","key":"2949_CR94","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1016\/j.vaccine.2007.03.052","volume":"25","author":"AC Maue","year":"2007","unstructured":"Maue AC, Waters WR, Palmer MV, Nonnecke BJ, Minion FC, Brown WC et al (2007) An ESAT-6: CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis. Vaccine 25(24):4735\u201346","journal-title":"Vaccine"},{"issue":"3\u20134","key":"2949_CR95","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.tube.2006.01.009","volume":"86","author":"J Dietrich","year":"2006","unstructured":"Dietrich J, Lundberg CV, Andersen P (2006) TB vaccine strategies\u2014what is needed to solve a complex problem? Tuberculosis 86(3\u20134):163\u2013168","journal-title":"Tuberculosis"},{"issue":"2","key":"2949_CR96","first-page":"89","volume":"4","author":"B Moradi","year":"2016","unstructured":"Moradi B, Sankian M, Amini Y, Meshkat Z (2016) Construction of a novel DNA vaccine candidate encoding an HspX-PPE44-EsxV fusion antigen of Mycobacterium tuberculosis. Rep Biochem Mol Biol 4(2):89","journal-title":"Rep Biochem Mol Biol"},{"issue":"48","key":"2949_CR97","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1016\/j.vaccine.2008.09.025","volume":"26","author":"M Romano","year":"2008","unstructured":"Romano M, Rindi L, Korf H, Bonanni D, Adnet P-Y, Jurion F et al (2008) Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c). Vaccine 26(48):6053\u20136063","journal-title":"Vaccine"},{"issue":"6","key":"2949_CR98","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1365-3083.2011.02531.x","volume":"73","author":"Q Li","year":"2011","unstructured":"Li Q, Yu H, Zhang Y, Wang B, Jiang W, Da Z et al (2011) Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Scand J Immunol 73(6):568\u2013576","journal-title":"Scand J Immunol"},{"issue":"3","key":"2949_CR99","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.biologicals.2011.02.002","volume":"39","author":"M Tebianian","year":"2011","unstructured":"Tebianian M, Hoseini AZ, Ebrahimi SM, Memarnejadian A, Mokarram AR, Mahdavi M et al (2011) Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70. Biologicals 39(3):143\u2013148","journal-title":"Biologicals"},{"issue":"4","key":"2949_CR100","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-3083.2010.02448.x","volume":"72","author":"H Zhang","year":"2010","unstructured":"Zhang H, Peng P, Miao S, Zhao Y, Mao F, Wang L et al (2010) Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice. Scand J Immunol 72(4):349\u2013357","journal-title":"Scand J Immunol"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-02949-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-022-02949-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-02949-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T08:23:01Z","timestamp":1744186981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-022-02949-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":100,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["2949"],"URL":"https:\/\/doi.org\/10.1007\/s00284-022-02949-8","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"22 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a review articles and it does not contain any with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"260"}}